Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 347-353

  Park, Haengnam ^a   Otani, Hajime ^a   Oishi, Chihiro ^a   Fujikawa, Mie ^a   Yamashita, Koji ^a   Okazaki, Toru ^a   Sato, Daisuke ^a   Ueyama, Takanao ^a   Iwasaka, Junji ^a   Yamamoto, Yoshihiro ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

blocker; Acute myocardial infarction; Pig; Reperfusion injury

Indexed keywords

CREATINE KINASE MB; LANDIOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY; EXPERIMENTAL PIG; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRA-ARTERIAL; MORPHOLINES; MYOCARDIAL INFARCTION; REPERFUSION INJURY; SWINE; TIME FACTORS; UREA;

EID: 78951471638     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.07.013     Document Type: Article

References (39)

1. K.A. Reimer, R.S. Vander Heide, and V.J. Richard Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models Am J Cardiol 72 1993 13G 21G
2. E. Boersma, N. Mercado, D. Poldermans, M. Gardien, J. Vos, and M.L. Simoons Acute myocardial infarction Lancet 361 2003 847 858
3. D. Yellon, and D. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
4. R.B. Jennings, K.A. Reimer, and C. Steenbergen Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion J Mol Cell Cardiol 18 1986 769 780
5. C. Ganote, and S. Armstrong Ischaemia and the myocyte cytoskeleton: review and speculation Cardiovasc Res 27 1993 1387 1403
6. G. Majno, and I. Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am J Pathol 146 1995 3 15
7. EM Antman, DT Anbe, and PW Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) Circulation 110 2004 e82 292
8. R.A. Kloner, and S.H. Rezkalla Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 44 2004 276 286
9. H. Otani Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities Antioxid Redox Signal 10 2008 207 247
10. M. Imamura, H.M. Lander, and R. Levi Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors Circ Res 78 1996 475 481
11. J Oka, M Imamura, and E Hatta Carrier-mediated norepinephrine release and reperfusion arrhythmias induced by protracted ischemia in isolated perfused guinea pig hearts: effect of presynaptic modulation by alpha(2)-adrenoceptor in mild hypothermic ischemia J Pharmacol Exp Ther 303 2002 681 687
12. H. Brunvand, P.M. Kvitting, S.E. Rynning, R.K. Berge, and K. Grong Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms J Cardiovasc Pharmacol 28 1996 409 417
13. B Ibanez, S Prat-Gonzalez, and WS Speidl Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916
14. A Halkin, CL Grines, and DA Cox Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 2004 1780 1787
15. E.R. Bates Role of intravenous beta-blockers in the treatment of ST-elevation myocardial infarction: of mice (dogs, pigs) and men Circulation 115 2007 2904 2906
16. M Pfisterer, JL Cox, and CB Granger Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries J Am Coll Cardiol 32 1998 634 640
17. ZM Chen, HC Pan, and YP Chen Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
18. U Piran, DW Kohn, and LS Uretsky Immunochemiluminometric assay of creatine kinase MB with a monoclonal antibody to the MB isoenzyme Clin Chem 33 1987 1517 1520
19. M.D. Sage, and R.B. Jennings Cytoskeletal injury and subsarcolemmal bleb formation in dog heart during in vitro total ischemia Am J Pathol 133 1988 327 337
20. H. Hammerman, R.A. Kloner, L.L. Briggs, and E. Braunwald Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol) J Am Coll Cardiol 3 1984 1438 1443
21. M.M. Rasmussen, K.A. Reimer, R.A. Kloner, and R.B. Jennings Infarct size reduction by propranolol before and after coronary ligation in dogs Circulation 56 1977 794 798
22. G.Z. Feuerstein, T.L. Yue, H.Y. Cheng, and R.R. Ruffolo Jr Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity J Hypertens Suppl 11 1993 S41 48
23. R. Lange, M.S. Nieminen, and R.A. Kloner Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques Cardiovasc Res 18 1984 37 43
24. K.B. Kern, R.W. Hilwig, A. Warner, M. Basnight, and G.A. Ewy Failure of intravenous metoprolol to limit acute myocardial infarct size in a nonreperfused porcine model Am Heart J 129 1995 650 655
25. S Kyoi, H Otani, and A Hamano Dystrophin is a possible end-target of ischemic preconditioning against cardiomyocyte oncosis during the early phase of reperfusion Cardiovasc Res 70 2006 354 363
26. I.S. Harper, and A. Lochner Sarcolemmal integrity during ischaemia and reperfusion of the isolated rat heart Basic Res Cardiol 84 1989 208 226
27. R.A. Kloner, J. Kirshenbaum, R. Lange, E.M. Antman, and E. Braunwald Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia Am J Cardiol 56 1985 40F 48F
28. A. Kitamura, A. Sakamoto, T. Inoue, and R. Ogawa Efficacy of an ultrashort-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation Eur J Clin Pharmacol 51 1997 467 471
29. S Iguchi, H Iwamura, and M Nishizaki Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101 Chem Pharm Bull 40 1992 1462 1469
30. D. Garcia-Dorado, P. Theroux, F. Fernandez-Aviles, J. Elizaga, J. Solares, and M. Galinanes Diltiazem and progression of myocardial ischemic damage during coronary artery occlusion and reperfusion in porcine hearts J Am Coll Cardiol 10 1987 906 911
31. P. Massoudy, B.F. Becker, C. Seligmann, and E. Gerlach Preischaemic as well as postischaemic application of a calcium antagonist affords cardioprotection in the isolated guinea pig heart Cardiovasc Res 29 1995 577 582
32. J. Odenstedt, C. Mansson, and L. Grip Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model J Cardiovasc Pharmacol 44 2004 407 415
33. A Cargnoni, C Ceconi, and P Bernocchi Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability Cardiovasc Res 47 2000 556 566
34. S. Kimura-Kurosawa, N. Kanaya, N. Kamada, N. Hirata, M. Nakayama, and A. Namiki Cardioprotective effect and mechanism of action of landiolol on the ischemic reperfused heart J Anesth 21 2007 480 489
35. S.H. Rezkalla, and R.A. Kloner Ischemic preconditioning and preinfarction angina in the clinical arena Nature Clin Pract 1 2004 96 102
36. M Sato, RM Engelman, and H Otani Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms Circulation 102 2000 III346 351
37. N Bao, S Minatoguchi, and H Kobayashi Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits Circ J 71 2007 1622 1628
38. M Kido, H Otani, and S Kyoi Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury Am J Physiol Heart Circ Physiol 287 2004 H81 90
39. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150